Imatinib (Gleevec generic): how this targeted therapy works
Imatinib was the first targeted cancer drug to prove that blocking a single abnormal protein could put leukaemia into remission.
Independent, judgement-free articles written by pharmacists and reviewed by clinicians. We explain how medications actually work, compare your options honestly, and tell you what to ask your doctor.
Imatinib was the first targeted cancer drug to prove that blocking a single abnormal protein could put leukaemia into remission.
Both medicines treat ED by blocking PDE5, but their onset and duration differ significantly. Here is what the evidence says.
12 condition hubs, each with treatment guides, side-effect explainers, and product comparisons.
Every article is written by a licensed pharmacist or doctor, and reviewed by a separate clinician before publication.
Every article is drafted by a licensed clinician with experience in that area.
A separate MD or PharmD reviews every piece for accuracy before it goes live.
Articles carry a last-reviewed date and are revisited whenever guidelines move.